While it has since retreated to 22c, Canaccord Genuity initiated coverage last week and set a price target of 55c.
“While PCK is in its early commercialisation phase, even revenue multiples don’t do justice to an assessment of the potential for this business,” Canaccord’s Martyn Jacobs said.
“This unique technology provides a breakthrough to an intractable problem in the aged care sector which is in desperate need of technological solutions to support the care of the elderly and particularly those living with dementia.”
Among predicted catalysts for growth were the expansion of the technology to infants as well as US FDA clearance.
- Forums
- ASX - By Stock
- PainChek General Discussion
While it has since retreated to 22c, Canaccord Genuity initiated...
-
- There are more pages in this discussion • 11,944 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $49.11M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 3.0¢ | $12.08K | 402.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 305189 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 99999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 305189 | 0.030 |
5 | 6607448 | 0.029 |
1 | 350000 | 0.028 |
3 | 488344 | 0.027 |
4 | 1600000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 99999 | 1 |
0.032 | 102605 | 2 |
0.033 | 126161 | 2 |
0.034 | 79638 | 2 |
0.035 | 125000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |